Navigation Links
Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
Date:7/30/2008

in listening to the live webcast should log on before the conference call begins to download any software required. Both the audio replay and the archive of the conference call webcast will remain available for several days.

ABOUT HUMAN GENOME SCIENCES

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax, cancer and other immune-mediated diseases. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing.

ABthrax(TM) (raxibacumab) is in late-stage development for the treatment of inhalation anthrax, and the Company is on track to begin the delivery in fall 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. HGS also has three drugs in clinical development for the treatment of cancer, including two TRAIL receptor antibodies and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins. In addition, HGS has substantial financial rights to three products in the GSK clinical development pipeline.

For more information about HGS, please visit the Company's web site at http://www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to clinical_trials@hgsi.com or by calling HGS at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

SAFE HARBOR STATEMENT

This announcement contains forward-looking statements within the me
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
2. Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results
3. New map IDs the core of the human brain
4. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
5. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
6. China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml)
7. MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources
8. Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
9. Robots moving closer to humans
10. Highest Replikin Concentrations and Cyclical Behavior Related to Human Mortality Are Found in Malaria Trypanosomes
11. Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... Drug safety specialty firm BioSot...g and Informatics earned the Certified Professiona...tial from the American Society for Training and De...e Flewell has more than fifteen years of medical c...and is responsible for the development of the comp...
(Date:11/5/2009)... Brooke Sanders brings a new look ... (PRWEB) November 5, 2009 -- Professional Reprogra...graphics company is pleased to present Brooke Sand...eir graphics/PR specialist. The addition of Brooke...t growth within Professional Reprographics., , ,Br...
(Date:11/4/2009)... The Human Anthrax Vaccine Program...mpleted the feature film "A Call to Arms:2009...tary "Fatal Immunity: The Human Anthrax Vacci...r and present danger of top secret government scie...with no accountability to its victims. It is avai...
(Date:11/4/2009)...ERSBURG, Va., Nov. 4 S...today that the company plans to introduce the CigR...diary, Rock Creek Pharmaceuticals, for worldwide m...Health, Inc . (Nasdaq: VTIV). inVentiv Health of...ns for every stage of the product lifecycle, in a ...
Breaking Biology Technology:BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4
...b. 11 BioMed Realty Trust, Inc. (NYSE: BMR ) an...he secured acquisition and interim loan facility o...venture with a fund managed by Prudential Real Est...approximately 600,000 square feet of life science ...rom the refinancing were approximately $203 millio...
...ss., Feb. 11 Idenix Pharmaceuticals, Inc., (Nasda...s financial results for the fourth quarter of 2008...ncial markets close. , , In conjunction with the ...ill host a conference call at 4:30 p.m. ET on Tues...nancial results for the fourth quarter of 2008. , ...
...S, Calif., Feb. 11 Nektar Therapeutics,(Nasdaq: ...e fourth quarter and,year ended December 31, 2008 ...f U.S.-based financial markets. Howard Robin, pre...nference call to review the results beginning at,5...(PT). , The press release and a live audio-onl...
Other Biology Technology:BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors 2BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors 3BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors 4Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets 2
(Date:11/6/2009)...o celebrate the 150th anniversary this month of th...rican Institute of Biological Sciences (AIBS) is p...bout Charles Darwin and his historic insights into...n of the University of California, Berkeley, and J...an,s article, "Ten Myths About Charles Darwin," ap...
(Date:11/5/2009)...ew Haven, Conn.Researchers at Yale University have...g the body,s immune response to HIV and HIV-infect...ir findings, published online in the Journal of t... therapeutic approaches for these diseases. , T... targeting HIV" (ARM-H) and "antibody-recruiting m...
(Date:11/4/2009)...t. Louis, MO, November 4, 2009 Childhood obesity ...ons. With more than one fourth of advertising on d...and beverages and continuing questions about the r...vember/December issue of the Journal of Nutrition...sing aimed at children might be a large contributo...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Gerton Lab determines the composition of centromeric chromatin 10126 1Gerton Lab determines the composition of centromeric chromatin 10126 2Sogeti USA Grows to Ensure Industry Expertise for Clients 58394 1Sogeti USA Grows to Ensure Industry Expertise for Clients 58394 2Sogeti USA Grows to Ensure Industry Expertise for Clients 58394 3Childrens Growth Charts Dont Measure Up With Parents 58390 1Childrens Growth Charts Dont Measure Up With Parents 58390 2Childrens Growth Charts Dont Measure Up With Parents 58390 3
...s almost quadruples a teenager,s risk of meningoco...e BMJ today. , Meningococcal disease is a life thr...rly childhood and in adolescence. , The incidenc... the United States rose dramatically during the 19...r this disease in adolescents. , The research te...
...wrong, researchers at the University of California...terial pathogens found in a number of troublesome ...ir wrong-doing is carried out by disguising themse... Ph.D., Dean for Scientific Affairs and Professor ...e at the UCSD School of Medicine; Neal M. Alto, Ph...
...ologists and computer scientists at the Universtit...owards cracking the code for how gene expression i...ed in Cell, in January 2006. , A genome milestone ...enome was completed. This has been followed by com...al species, for example mouse, dog, cow and chicke...
Other Biology News:UCSD team unmasks family of immune system invaders 2UCSD team unmasks family of immune system invaders 3Cracking the genetic code for control of gene expression 2
Biolase DNA Polymerase from Bioline
...units/µL ,• High specific activity an...Leaves an 'A' overhang ,• Processes ,A ...gh activity in primer extension and other molecula...he enzyme, each lot has been functionally tested f...
Aspergillus-directed IgG EIA Kit from Alpco Diagnostics
Ps-Aeruginosa-directed IgA EIA Kit from Alpco Diagnostics
Biology Products: